| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 7507911 | Drug and Alcohol Dependence | 2012 | 5 Pages |
Abstract
AChEIs, such as donepezil, may have pro-cognitive effects among healthy smokers while they continue to smoke as usual. Given the association between cognitive deficits and relapse, AChEIs should be explored as potential therapeutics for smoking cessation.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Rebecca L. Ashare, Riju Ray, Caryn Lerman, Andrew A. Strasser,